• Explore /
  • Poster
  • / Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311).

Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311).

Abstract Video & Slides Poster

Authors

null

Robert L. Ferris

University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA

Robert L. Ferris , Yael Flamand , Gregory S. Weinstein , Shuli Li , Harry Quon , Ranee Mehra , Joaquin J. Garcia , Jolie Ringash , Jan S. Lewin , Umamaheswar Duvvuri , Bert W. O'Malley , Enver Ozer , Giovana R. Thomas , Wayne Koch , Michael Elliot Kupferman , Richard Bryan Bell , Nabil F. Saba , Miriam Lango , Lynne I. Wagner , Barbara Burtness

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT 01898494

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 6010)

DOI

10.1200/JCO.2021.39.15_suppl.6010

Abstract #

6010

Abstract Disclosures

Similar Posters

First Author: Margaret Winn Kendrick

First Author: Yanfeng Chen

First Author: Heath Devin Skinner

First Author: Juan W. Valle